Sign In
Last checked at 
21 Feb 2022 07:00
21 February 2022
Diaceutics PLC
("Diaceutics" or the "Group" or the "Company")
Investor Presentation
Ā
Diaceutics PLC (AIM: DXRX), theĀ diagnostic commercialisation company, announces that CEO Peter Keeling and incoming CFO Nick Roberts willĀ provide a live presentation relating to the Company'sĀ audited results for the year ended 31 December 2021 via the Investor Meet Company platform onĀ 23 March 2022 at 1pm.
Ā
The presentation is open to all existing and potential shareholders and registration can be completed via the following link:
Ā
https://www.investormeetcompany.com/diaceutics-plc/register-investor.
Ā
Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.
Ā
Investors who already followĀ Diaceutics on the Investor Meet Company platform will automatically be invited.
Ā
Enquiries:
Diaceutics PLCĀ Peter Keeling, Chief Executive Officer Ā Stifel Nicolaus Europe Limited (Nomad & Broker) Ben Maddison Stewart Wallace Nick Adams Ā Alma PR Caroline Forde Kieran Breheny Matthew Young | Ā Via Alma PR Ā Tel: +44 (0)20 7710 7600 Ā Ā Tel: +44(0)20 3405 0205 diaceutics@almapr.co.uk Ā Ā |
About Diaceutics
At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world's leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX - The Diagnostic NetworkĀ®.Ā
DXRX is the world's first diagnostic commercialisation platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories.
Ā
Follow the stocks
